BACKGROUND: We investigated to what extent cognitive impairment and dementia were related to the direct medical and nonmedical costs in Parkinson's disease. METHODS: Sixty-one patients with Parkinson's disease from a population-based cohort were assessed for motor and cognitive symptoms in 1993, 1997, and 2001. Data on use of health care and social services were collected. RESULTS: The costs of patients with dementia were 3.3 times higher (€34,980) than those of nondemented patients (€10,626) per year of survival. Institutional care was the largest cost factor, representing 67% of the costs. Cognitive functioning predicted direct costs by 29.4%. Cognitive decline was associated with increased costs, even in nondemented subjects. CONCLUSIONS: Our findings suggest that dementia has a substantial impact on direct costs in Parkinson's disease, mainly due to high costs for institutional care. In addition, there were indications that even patients with mild cognitive impairment have higher nonmedical costs.
BACKGROUND: We investigated to what extent cognitive impairment and dementia were related to the direct medical and nonmedical costs in Parkinson's disease. METHODS: Sixty-one patients with Parkinson's disease from a population-based cohort were assessed for motor and cognitive symptoms in 1993, 1997, and 2001. Data on use of health care and social services were collected. RESULTS: The costs of patients with dementia were 3.3 times higher (€34,980) than those of nondemented patients (€10,626) per year of survival. Institutional care was the largest cost factor, representing 67% of the costs. Cognitive functioning predicted direct costs by 29.4%. Cognitive decline was associated with increased costs, even in nondemented subjects. CONCLUSIONS: Our findings suggest that dementia has a substantial impact on direct costs in Parkinson's disease, mainly due to high costs for institutional care. In addition, there were indications that even patients with mild cognitive impairment have higher nonmedical costs.
Authors: Nicholas T Bott; Erica T Johnson; Norbert Schuff; Nicholas Galifianakis; Trishna Subas; Jessica Pollock; Peter Pressman; Joel H Kramer; Katherine L Possin Journal: Parkinsonism Relat Disord Date: 2014-10-15 Impact factor: 4.891
Authors: Jennifer Y Y Szeto; Courtney C Walton; Alexandra Rizos; Pablo Martinez-Martin; Glenda M Halliday; Sharon L Naismith; K Ray Chaudhuri; Simon J G Lewis Journal: NPJ Parkinsons Dis Date: 2020-01-07
Authors: Ondrej Bezdicek; Markéta Červenková; Tyler M Moore; Hana Stepankova Georgi; Zdenek Sulc; David A Wolk; Daniel A Weintraub; Paul J Moberg; Robert Jech; Miloslav Kopecek; David R Roalf Journal: Assessment Date: 2018-06-21
Authors: Jennifer G Goldman; Glenn T Stebbins; Vania Leung; Barbara C Tilley; Christopher G Goetz Journal: Parkinsonism Relat Disord Date: 2014-08-13 Impact factor: 4.891
Authors: Inger van Steenoven; Dag Aarsland; Howard Hurtig; Alice Chen-Plotkin; John E Duda; Jacqueline Rick; Lama M Chahine; Nabila Dahodwala; John Q Trojanowski; David R Roalf; Paul J Moberg; Daniel Weintraub Journal: Mov Disord Date: 2014-11-07 Impact factor: 10.338
Authors: Joseph DeGutis; Mallory Grosso; Thomas VanVleet; Michael Esterman; Laura Pistorino; Alice Cronin-Golomb Journal: Neurocase Date: 2015-09-11 Impact factor: 0.881
Authors: Dag Aarsland; Lucia Batzu; Glenda M Halliday; Gert J Geurtsen; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub Journal: Nat Rev Dis Primers Date: 2021-07-01 Impact factor: 52.329
Authors: Ondrej Bezdicek; Tomas Nikolai; Jiri Michalec; Filip Růžička; Petra Havránková; Jan Roth; Robert Jech; Evžen Růžička Journal: Mov Disord Clin Pract Date: 2016-07-08